NCT00143533View on ClinicalTrials.gov

Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

September 30, 2010

Study Completion Date

June 30, 2011

Conditions
NeoplasmDiarrhea
Interventions
DRUG

Irinotecan, Cefpodoxime

See Detailed description section for treatment details.

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

St. Jude Children's Research Hospital

OTHER

NCT00143533 - Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors | Biotech Hunter | Biotech Hunter